Together with St. Michael's Hospital, the Biomedical Zone is addressing this challenge with startups based in the Greater Toronto Area. Selected startups will receive direct clinical and administrative access and mentorship and support from St. Michael's IT, business advisors, clinicians and end users.
OCHIS - Innovation Brokers
The Value-Based Innovation Program (VBIP) provides a new way for our health system to procure and adopt innovative technologies and processes that ensure greater value for Ontarians. The Value-Based Innovation Program leverages Ontario's single-payer health care system as a demand-driver for health technology solutions and processes that can be rapidly assessed, sourced and integrated into clinical practice and spread across the province.
Nuclis de recerca industrial i desenvolupament experimental, 2017. Nuclis Internacionals Unilaterals 2st Call
Ajuts destinats a incentivar la realització d’activitats de R+D amb abast internacional. Àmbits territorials elegibles: UE-28 (excepte Alemanya i Espanya), Cuba, Canadà, Massachusetts, Corea del Sud, Xina i Singapur.
Canada has the highest rate of multiple sclerosis. Now St. Michael's Hospital is launching a $30M centre to fight MS | Toronto Star
The Barlo MS Centre, funded mainly by donations, is expected to be a global leader in multiple sclerosis care and research.
CTAs now accepting applications for Spring 2018 Cohorts
We are pleased to announce that the Canadian Technology Accelerator (CTA) initiative is now accepting applications for our spring 2018 cohorts (February–June 2018). Programs will be running simultaneously in Boston, New York City, and Silicon Valley. What is it? The CTA helps innovative Canadian technology companies accelerate their international growth through a 5-month program of workshops, events, mentorship and business introductions. For more information please visit: international.gc.ca/trade-commerce/cta-atc.
Genomic Applications Partnership Program (GAPP) - Ontario Genomics
The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects that address real world opportunities and challenges identified by industry, government, not-for-profits and other “Receptors” of genomics knowledge and technologies. GAPP projects are collaborations between academic researchers and Receptor organizations. They are co-funded by Receptors and other stakeholders, and have the potential...Read More
Fact Sheet Life Science Council Apply Through our annual Health Innovation Hub: Digital Health, venture catalyst Springboard Enterprises will partner with 10-15 women-led digital health companies seeking funding or strategic partners and empower the women leaders of those companies with access to a suite of relevant experts, services, & resources.